Sandra D. Laufer

509 total citations
6 papers, 153 citations indexed

About

Sandra D. Laufer is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Sandra D. Laufer has authored 6 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Genetics. Recurrent topics in Sandra D. Laufer's work include Cardiomyopathy and Myosin Studies (3 papers), Pluripotent Stem Cells Research (2 papers) and CRISPR and Genetic Engineering (2 papers). Sandra D. Laufer is often cited by papers focused on Cardiomyopathy and Myosin Studies (3 papers), Pluripotent Stem Cells Research (2 papers) and CRISPR and Genetic Engineering (2 papers). Sandra D. Laufer collaborates with scholars based in Germany, United States and United Kingdom. Sandra D. Laufer's co-authors include Thomas Eschenhagen, Giulia Mearini, Elisabeth Krämer, Frederik Flenner, Charles Redwood, Oliver J. Müller, Arne Hansen, Aya Shibamiya, Julia Münch and Monica Patten and has published in prestigious journals such as Circulation, Cell Death and Disease and Molecular Therapy — Nucleic Acids.

In The Last Decade

Sandra D. Laufer

6 papers receiving 150 citations

Peers

Sandra D. Laufer

MB

CCM

GENET

CR

SURGE

Dao Wu Wang China

Elisa Mastantuono Germany

Kingsley Chow United States

Giulia Poloni Italy

Angela C. Tai United States

Mary Anne S. Amper United States

Gaëlle Auguste United States

L. M. Dorsch Netherlands

Azadeh Alikashani Canada

Monique Ohanian Australia

Dao Wu Wang China

Sandra D. Laufer

77 ×0.7

MB

102 ×1.3

CCM

15 ×1.1

GENET

10 ×0.8

CR

6 ×0.6

SURGE

Citations per year, relative to Sandra D. Laufer Sandra D. Laufer (= 1×) peers Dao Wu Wang

Countries citing papers authored by Sandra D. Laufer

Since Specialization

Citations

This map shows the geographic impact of Sandra D. Laufer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra D. Laufer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra D. Laufer more than expected).

Fields of papers citing papers by Sandra D. Laufer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra D. Laufer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra D. Laufer. The network helps show where Sandra D. Laufer may publish in the future.

Co-authorship network of co-authors of Sandra D. Laufer

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra D. Laufer. A scholar is included among the top collaborators of Sandra D. Laufer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra D. Laufer. Sandra D. Laufer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Dittmann, Sven, et al.. (2024). Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A). Stem Cell Research. 78. 103446–103446. 1 indexed citations

2.

Maver, Aleš, Ashraf Yusuf Rangrez, Marijana Ćorić, et al.. (2022). A biallelic loss-of-function variant in MYZAP is associated with a recessive form of severe dilated cardiomyopathy. Molecular Case Studies. 8(5). a006221–a006221. 4 indexed citations

3.

Ulmer, Bärbel, Sandra D. Laufer, Aya Shibamiya, et al.. (2021). Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy. Stem Cell Research. 55. 102489–102489. 6 indexed citations

4.

Xie, Wanhua, Michaela Miehe, Sandra D. Laufer, & Steven A. Johnsen. (2020). The H2B ubiquitin-protein ligase RNF40 is required for somatic cell reprogramming. Cell Death and Disease. 11(4). 287–287. 15 indexed citations

5.

Krause, Julia, Marc N. Hirt, Sandra D. Laufer, et al.. (2020). An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility. Circulation. 142(16). 1562–1578. 56 indexed citations

6.

Prondzynski, Maksymilian, Elisabeth Krämer, Sandra D. Laufer, et al.. (2017). Evaluation of MYBPC3 trans -Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes. Molecular Therapy — Nucleic Acids. 7. 475–486. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact